Evidence map›Paper›PMID 27791101›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Oxygen delivery using engineered microparticles.

Raymond P Seekell, Andrew T Lock, Yifeng Peng, Alexis R Cole, Dorothy A Perry, John N Kheir, Brian D Polizzotti

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Gas Delivery Relevant to Human Health using Porous Materials.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. A microfluidic device for real-time on-demand intravenous oxygen delivery.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Review
  14. Article
  15. A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Reply to Span et al.: Rational design of oxygen microparticles for radiation therapy.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Raymond P SeekellDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115.
Andrew T LockDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115.
Yifeng PengDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115.
Alexis R ColeDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115.
Dorothy A PerryDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115.
John N KheirDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115.
Brian D PolizzottiDivision of Basic Cardiovascular Research, Department of Cardiology, Boston Children's Hospital, Boston, MA 02115; brian.polizzotti@cardio.chboston.org.

Funding

Boston Biomedical Innovation CenterU54HL119145 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLAN, DAVID E., LOSCALZO, JOSEPH · 2013 to 2021
$18.8M
NHLBI NIH HHS U54 HL119145
6 · The paper itself

Abstract

A continuous supply of oxygen to tissues is vital to life and interruptions in its delivery are poorly tolerated. The treatment of low-blood oxygen tensions requires restoration of functional airways and lungs. Unfortunately, severe oxygen deprivation carries a high mortality rate and can make otherwise-survivable illnesses unsurvivable. Thus, an effective and rapid treatment for hypoxemia would be revolutionary. The i.v. injection of oxygen bubbles has recently emerged as a potential strategy to rapidly raise arterial oxygen tensions. In this report, we describe the fabrication of a polymer-based intravascular oxygen delivery agent. Polymer hollow microparticles (PHMs) are thin-walled, hollow polymer microcapsules with tunable nanoporous shells. We show that PHMs are easily charged with oxygen gas and that they release their oxygen payload only when exposed to desaturated blood. We demonstrate that oxygen release from PHMs is diffusion-controlled, that they deliver approximately five times more oxygen gas than human red blood cells (per gram), and that they are safe and effective when injected in vivo. Finally, we show that PHMs can be stored at room temperature under dry ambient conditions for at least 2 mo without any effect on particle size distribution or gas carrying capacity.

Indexed as

AnimalsCapsulesDrug Delivery SystemsDrug LiberationHumansInjections, IntravenousKineticsMaleNanoporesOxygenParticle SizePolymersPorosityRats, Sprague-DawleyReproducibility of ResultsCapsulesOxygenPolymerscolloidscore–shellhypoxemiamicroparticleoxygen

Identifiers

PMID27791101
PMCPMC5098671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.